Iakovos Kritikos

Mr. Iakovos Kritikos

Bioengineering, Imperial College London, London, City of London, UK
+3
orcid
Biomedical Engineer

Biography

Iakovos Kritikos is a senior research informatics and automation professional working in R&D at Eli Lilly in Boston, where he designs and leads scalable, compliant informatics platforms that integrate multimodal scientific data across global research environments. His work spans high‑throughput data architectures, laboratory automation, AI‑enabled inspection systems, and resilient data pipelines supporting life‑science discovery, significantly improving reproducibility, throughput, and time‑to‑data. He holds dual degrees in Electrical and Computer Engineering from the National Technical University of Athens, an MSc and MRes in Biomedical Engineering from Imperial College London, and a Master of Engineering Management from Duke University, and is currently pursuing a Doctorate in Business Administration in Health at UCL, focused on the quantitative evaluation of AI and technology investments in drug discovery. His research background includes machine learning for biomedical signal analysis, time‑frequency modeling of blood–brain barrier permeability, virtual and augmented reality systems for neuroengineering, and embedded and computational systems for miniature mass spectrometry. He has authored peer‑reviewed publications across neuroscience, biomedical engineering, virtual reality, and AI in pharma R&D, and has presented his work at leading international conferences. His career reflects a consistent focus on bridging advanced engineering and strategic decision‑making.

Affiliations

Imperial College London

London, City of London, UK

Bioengineering

Duke University

Durham, California, USA

Engineering

National Technical University of Athens

Athens, Attikí, Greece

Electrical and Computer Engineering

University College London

London, City of London, UK

GLOBAL BUSINESS SCHOOL FOR HEALTH

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.